Steven R. Vigna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Steven R. Vigna has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Douglas C. McVey
From the Departments of *Cell Biology & Medicine, †Medicine, and ‡Surgery, Duke University Medical Center, Durham, NC
6 shared publications- Rodger A. Liddle
Department of Medicine, Duke University, Durham, North Carolina, USA
5 shared publications Rafiq A. Shahid
4 shared publicationsAkash A. Patel
1 shared publicationB. A. Himick
Department of Biological Sciences, University of Alberta, Edmonton, Canada
1 shared publicationC.R. Mantyh
Department of Surgery, Duke University Medical Center, Durham, NC USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2017
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2017, 1-8
Intraluminal Administration of Resiniferatoxin Protects againstClostridium difficileToxin A-Induced Colitis
Clostridium difficiletoxin A is a colonic inflammatory agent that acts partially by activation of TRPV1 (transient receptor potential vanilloid type 1). Resiniferatoxin (RTX) is an excitotoxin that activates TRPV1 at low concentrations and defunctionalizes TRPV1 at high concentrations. RTX at various doses was injected intraluminally into isolated ileal segments in anesthetized rats. After 3 hours, the treated segments were removed and inflammation was assessed. This acute treatment with RTX resulted in biphasic responses: (1) an increase in inflammation similar to that caused by toxin A and capsaicin at low doses of up to 100 ng RTX and (2) no inflammatory effect of RTX at higher doses (1–100 μg), consistent with a defunctionalizing or neurotoxic effect of RTX at high doses. Separately, anesthetized rats were treated with RTX enemas and one or four weeks later were challenged with toxin A. Toxin A-induced colitis was significantly inhibited one week after an RTX enema, and this effect was RTX dose dependent. When tested four weeks after administration of the RTX enema, protection against toxin A colitis was lost. In conclusion, an RTX enema protects against toxin A-induced colitis in rats for at least one week but less than four weeks.
- 1 January 2017
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2017, 1-8
Open AccessIntraluminal Administration of Resiniferatoxin Protects againstClostridium difficileToxin A-Induced Colitis
Clostridium difficiletoxin A is a colonic inflammatory agent that acts partially by activation of TRPV1 (transient receptor potential vanilloid type 1). Resiniferatoxin (RTX) is an excitotoxin that activates TRPV1 at low concentrations and defunctionalizes TRPV1 at high concentrations. RTX at various doses was injected intraluminally into isolated ileal segments in anesthetized rats. After 3 hours, the treated segments were removed and inflammation was assessed. This acute treatment with RTX resulted in biphasic responses: (1) an increase in inflammation similar to that caused by toxin A and capsaicin at low doses of up to 100 ng RTX and (2) no inflammatory effect of RTX at higher doses (1–100 μg), consistent with a defunctionalizing or neurotoxic effect of RTX at high doses. Separately, anesthetized rats were treated with RTX enemas and one or four weeks later were challenged with toxin A. Toxin A-induced colitis was significantly inhibited one week after an RTX enema, and this effect was RTX dose dependent. When tested four weeks after administration of the RTX enema, protection against toxin A colitis was lost. In conclusion, an RTX enema protects against toxin A-induced colitis in rats for at least one week but less than four weeks.
- Open Access
- 11 January 2016
- Published by Wiley in International Journal of Inflammation
- Vol. 2016, 1-10
Nicotine InhibitsClostridium difficileToxin A-Induced Colitis but Not Ileitis in Rats
Nicotine is protective in ulcerative colitis but not Crohn’s disease of the small intestine, but little is known about the effects of nicotine onClostridium difficiletoxin A-induced enteritis. Isolated ileal or colonic segments in anesthetized rats were pretreated with nicotine bitartrate or other pharmacological agents before intraluminal injection of toxin A. After 3 hours, the treated segments were removed and inflammation was assessed. Nicotine biphasically inhibited toxin A colitis but not ileitis. Pretreatment with the nicotinic receptor antagonist, hexamethonium, blocked the effects of nicotine. Pretreating the colonic segments with hexamethonium before toxin A administration resulted in more inflammation than seen with toxin A alone, suggesting that a tonic nicotinic anti-inflammatory condition exists in the colon. Nicotine also inhibited toxin A-induced increased colonic concentrations of the TRPV1 (transient receptor potential vanilloid subtype 1) agonist, leukotriene B4(LTB4), and release of the proinflammatory neuropeptide, substance P. Pretreatment with nicotine did not protect against direct TRPV1-mediated colitis caused by intraluminal capsaicin. Nicotinic cholinergic receptors tonically protect the colon against inflammation and nicotine inhibits toxin A colitis but not toxin A ileitis in rats in part by inhibition of toxin A-induced activation of TRPV1 by endogenous TRPV1 agonists such as LTB4.
- 11 January 2016
- Published by Wiley in International Journal of Inflammation
- Vol. 2016, 1-10
Open AccessNicotine InhibitsClostridium difficileToxin A-Induced Colitis but Not Ileitis in Rats
Nicotine is protective in ulcerative colitis but not Crohn’s disease of the small intestine, but little is known about the effects of nicotine onClostridium difficiletoxin A-induced enteritis. Isolated ileal or colonic segments in anesthetized rats were pretreated with nicotine bitartrate or other pharmacological agents before intraluminal injection of toxin A. After 3 hours, the treated segments were removed and inflammation was assessed. Nicotine biphasically inhibited toxin A colitis but not ileitis. Pretreatment with the nicotinic receptor antagonist, hexamethonium, blocked the effects of nicotine. Pretreating the colonic segments with hexamethonium before toxin A administration resulted in more inflammation than seen with toxin A alone, suggesting that a tonic nicotinic anti-inflammatory condition exists in the colon. Nicotine also inhibited toxin A-induced increased colonic concentrations of the TRPV1 (transient receptor potential vanilloid subtype 1) agonist, leukotriene B4(LTB4), and release of the proinflammatory neuropeptide, substance P. Pretreatment with nicotine did not protect against direct TRPV1-mediated colitis caused by intraluminal capsaicin. Nicotinic cholinergic receptors tonically protect the colon against inflammation and nicotine inhibits toxin A colitis but not toxin A ileitis in rats in part by inhibition of toxin A-induced activation of TRPV1 by endogenous TRPV1 agonists such as LTB4.
- Open Access
- 1 January 2014
- Published by Wiley in International Journal of Inflammation
- Vol. 2014, 1-10
5-Aminosalicylic Acid Inhibits AcuteClostridium difficileToxin A-Induced Colitis in Rats
We tested the hypothesis that 5-aminosalicylic acid (5-ASA) inhibits toxin A-induced generation of colonic leukotriene B4(LTB4) and toxin A colitis in rats. Isolated colonic segments in anesthetized rats were treated intraluminally with toxin A for 3 hours with or without 30 minutes of pretreatment with either 5-ASA or sulfapyridine and then colonic tissue levels of LTB4were measured and inflammation was assessed. Separately, sulfasalazine was administered to rats in their drinking water for 5 days, isolated colonic segments were then prepared, toxin A was administered, and inflammation was assessed as before. Pretreatment with 5-ASA inhibited toxin A-induced increased tissue LTB4concentration in the colon. Sulfasalazine and 5-ASA but not sulfapyridine significantly inhibited toxin A colitis. However, pretreatment with 5-ASA did not protect against direct TRPV1-mediated colitis caused by capsaicin. Toxin A stimulated the release of substance P (SP), and this effect was also inhibited by sulfasalazine and 5-ASA but not by sulfapyridine. Thus, toxin A stimulates colonic LTB4resulting in activation of TRPV1, release of SP, and colitis. Inhibition of 5-LO by 5-ASA disrupts this pathway and supports the concept that LTB4activation of TRPV1 plays a role in toxin A colitis.
- 1 January 2014
- Published by Wiley in International Journal of Inflammation
- Vol. 2014, 1-10
Open Access5-Aminosalicylic Acid Inhibits AcuteClostridium difficileToxin A-Induced Colitis in Rats
We tested the hypothesis that 5-aminosalicylic acid (5-ASA) inhibits toxin A-induced generation of colonic leukotriene B4(LTB4) and toxin A colitis in rats. Isolated colonic segments in anesthetized rats were treated intraluminally with toxin A for 3 hours with or without 30 minutes of pretreatment with either 5-ASA or sulfapyridine and then colonic tissue levels of LTB4were measured and inflammation was assessed. Separately, sulfasalazine was administered to rats in their drinking water for 5 days, isolated colonic segments were then prepared, toxin A was administered, and inflammation was assessed as before. Pretreatment with 5-ASA inhibited toxin A-induced increased tissue LTB4concentration in the colon. Sulfasalazine and 5-ASA but not sulfapyridine significantly inhibited toxin A colitis. However, pretreatment with 5-ASA did not protect against direct TRPV1-mediated colitis caused by capsaicin. Toxin A stimulated the release of substance P (SP), and this effect was also inhibited by sulfasalazine and 5-ASA but not by sulfapyridine. Thus, toxin A stimulates colonic LTB4resulting in activation of TRPV1, release of SP, and colitis. Inhibition of 5-LO by 5-ASA disrupts this pathway and supports the concept that LTB4activation of TRPV1 plays a role in toxin A colitis.
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Sa1851 Bile Acid-Induced Acute Pancreatitis Is Mediated by Acinar Cell Leukotriene B4 Secretion
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Sa1851 Bile Acid-Induced Acute Pancreatitis Is Mediated by Acinar Cell Leukotriene B4 Secretion
- Open Access
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
29 Immunoglobulin-Like Domain Containing Receptor Mediates Fat-Stimulated Cholecystokinin Secretion
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Open Access29 Immunoglobulin-Like Domain Containing Receptor Mediates Fat-Stimulated Cholecystokinin Secretion
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Sa1479 Leukotriene B4 Activation of TRPV1 Mediates Acute Pancreatitis Induced by Pancreatic Duct Infusion of Sodium Taurocholate in Mice
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Sa1479 Leukotriene B4 Activation of TRPV1 Mediates Acute Pancreatitis Induced by Pancreatic Duct Infusion of Sodium Taurocholate in Mice
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Su1247 The Role of TRPV1 in Ethanol Plus Fatty Acid-Induced Acute Pancreatitis in Mice
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Su1247 The Role of TRPV1 in Ethanol Plus Fatty Acid-Induced Acute Pancreatitis in Mice
- 1 July 2011
- Published by Wolters Kluwer Health in Pancreas
- Vol. 40 (5) , 708-714
Leukotriene B4 Mediates Inflammation via TRPV1 in Duct Obstruction-Induced Pancreatitis in Rats
Objectives: We tested the hypothesis that leukotriene B4 (LTB4) mediates pancreatic inflammation in rats via activation of the transient receptor potential vanilloid 1 (TRPV1). Methods: Leukotriene B4 or a vehicle was administered to adult rats via celiac axis injection after pretreatment with the TRPV1 antagonist, capsazepine, or vehicle, and the severity of subsequent pancreatitis was assessed by measuring pancreatic edema, myeloperoxidase (MPO) activity, and histological grading. In a second experiment, acute pancreatitis was induced by common pancreaticobiliary duct ligation. Six hours after surgery, pancreatic tissue levels of LTB4 were determined by enzyme-linked immunosorbent assay. Also, the effects of inhibition of LTB4 biosynthesis by pretreatment with the 5-lipoxygenase-activating peptide inhibitor, MK-886, were determined. Results: Celiac axis administration of LTB4 significantly increased pancreatic edema and MPO activity, and produced histological evidence of pancreatic edema, neutrophil infiltration, and necrosis. Capsazepine pretreatment significantly reduced all inflammatory parameters in LTB4-induced pancreatitis. Pancreatic tissue levels of LTB4 were significantly elevated in rats that underwent common pancreaticobiliary duct ligation compared with control rats. MK-886 pretreatment significantly inhibited pancreatic edema, histological damage, and pancreatic MPO concentrations. Conclusions: Common pancreaticobiliary duct obstruction causes an increase in pancreatic LTB4 concentrations that in turn mediates activation of TRPV1 resulting in acute pancreatitis.
- 1 July 2011
- Published by Wolters Kluwer Health in Pancreas
- Vol. 40 (5) , 708-714
Leukotriene B4 Mediates Inflammation via TRPV1 in Duct Obstruction-Induced Pancreatitis in Rats
Objectives: We tested the hypothesis that leukotriene B4 (LTB4) mediates pancreatic inflammation in rats via activation of the transient receptor potential vanilloid 1 (TRPV1). Methods: Leukotriene B4 or a vehicle was administered to adult rats via celiac axis injection after pretreatment with the TRPV1 antagonist, capsazepine, or vehicle, and the severity of subsequent pancreatitis was assessed by measuring pancreatic edema, myeloperoxidase (MPO) activity, and histological grading. In a second experiment, acute pancreatitis was induced by common pancreaticobiliary duct ligation. Six hours after surgery, pancreatic tissue levels of LTB4 were determined by enzyme-linked immunosorbent assay. Also, the effects of inhibition of LTB4 biosynthesis by pretreatment with the 5-lipoxygenase-activating peptide inhibitor, MK-886, were determined. Results: Celiac axis administration of LTB4 significantly increased pancreatic edema and MPO activity, and produced histological evidence of pancreatic edema, neutrophil infiltration, and necrosis. Capsazepine pretreatment significantly reduced all inflammatory parameters in LTB4-induced pancreatitis. Pancreatic tissue levels of LTB4 were significantly elevated in rats that underwent common pancreaticobiliary duct ligation compared with control rats. MK-886 pretreatment significantly inhibited pancreatic edema, histological damage, and pancreatic MPO concentrations. Conclusions: Common pancreaticobiliary duct obstruction causes an increase in pancreatic LTB4 concentrations that in turn mediates activation of TRPV1 resulting in acute pancreatitis.
- 1 May 2005
- Published by Elsevier in Gastroenterology
- Vol. 128 (5) , 1306-1316
The Role of Leukotriene B4 in Clostridium difficile Toxin A--Induced Ileitis in Rats
- 1 May 2005
- Published by Elsevier in Gastroenterology
- Vol. 128 (5) , 1306-1316
The Role of Leukotriene B4 in Clostridium difficile Toxin A--Induced Ileitis in Rats
- 30 April 2000
- Published by Elsevier in Gastroenterology
- Vol. 118 (4) , A327
The capsaicin VR1 receptor mediates the effects of Clostridium difficile toxin A-induced enteritis in rats
- 30 April 2000
- Published by Elsevier in Gastroenterology
- Vol. 118 (4) , A327
The capsaicin VR1 receptor mediates the effects of Clostridium difficile toxin A-induced enteritis in rats